Oct
07
2022
Roswell Cancer Center praises Cuba´s VSSP cancer drug effectiveness
The Roswell Park Comprehensive Cancer Center (EPCCC) in the United States on Thursday reported that Cuba´s VSSP cancer drug effectiveness on metastatic kidney cancer paves the way for a new treatment on such a disease.
According to a collaborative effort among EPCCC researchers and Cuba´s Center for Molecular Immunology (CIM), it was created a new strategy to correct immune dysfunction in patients suffering from malignant tumors, the source said.
